Frank Michael Klenke
Department of Orthopedic Surgery
Inselspital
University of Bern
CH-3010 Bern
Switzerland
Name/email consistency: high
- Impact of pore size on the vascularization and osseointegration of ceramic bone substitutes in vivo. Klenke, F.M., Liu, Y., Yuan, H., Hunziker, E.B., Siebenrock, K.A., Hofstetter, W. J. Biomedical Materials Research. (2008)
- Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth via antiangiogenesis in vivo. Klenke, F.M., Abdollahi, A., Bertl, E., Gebhard, M.M., Ewerbeck, V., Huber, P.E., Sckell, A. BMC. Cancer (2007)
- The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in mice. Klenke, F.M., Gebhard, M.M., Ewerbeck, V., Abdollahi, A., Huber, P.E., Sckell, A. BMC. Cancer (2006)